Search research articles
Contact Us
Filters
Showing results (521-530 of 622) with videos related to
Page
of 63
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study
Niall C Tebbutt, Kate Wilson, Val J Gebski, et al.
Gut
|
September 5, 2020
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours
Kate Young, Rita T Lawlor, Chanthirika Ragulan, et al.
JCO Precision Oncology
|
March 9, 2022
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
Pashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, et al.
Scientific Reports
|
January 25, 2018
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Francesco Sclafani, Ian Chau, David Cunningham, et al.
Journal of AOAC International
|
August 14, 2017
AOAC SMPR® 2017.003
Brian T Schaneberg, Paula N Brown, Anton Bzhelyansky, et al.
Annals of Hematology
|
February 3, 2026
Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial
Yasmin H Karimi, Chan Y Cheah, Michael Roost Clausen, et al.
Frontiers in Oncology
|
October 5, 2020
Diagnostic Accuracy and Safety of Coaxial System in Oncology Patients Treated in a Specialist Cancer Center With Prospective Validation Within Clinical Trial Data
Khurum Khan, Reyes Gonzalez-Exposito, David Cunningham, et al.
Hemasphere
|
December 13, 2021
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma
Graham P Collins, Toby A Eyre, Debora Schmitz-Rohmer, et al.
Journal of AOAC International
|
August 14, 2017
AOAC SMPR® 2017.004
Brian T Schaneberg, Paula N Brown, Anton Bzhelyansky, et al.
Carcinogenesis
|
July 7, 2016
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients
Francesco Sclafani, Ian Chau, David Cunningham, et al.
Page
of 63
Search research articles
Search
Showing results (521-530 of 622) with videos related to
Sort By:
Page
of 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study
Niall C Tebbutt, Kate Wilson, Val J Gebski, et al.
Gut
|
September 5, 2020
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours
Kate Young, Rita T Lawlor, Chanthirika Ragulan, et al.
JCO Precision Oncology
|
March 9, 2022
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
Pashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, et al.
Scientific Reports
|
January 25, 2018
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Francesco Sclafani, Ian Chau, David Cunningham, et al.
Journal of AOAC International
|
August 14, 2017
AOAC SMPR® 2017.003
Brian T Schaneberg, Paula N Brown, Anton Bzhelyansky, et al.
Annals of Hematology
|
February 3, 2026
Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial
Yasmin H Karimi, Chan Y Cheah, Michael Roost Clausen, et al.
Frontiers in Oncology
|
October 5, 2020
Diagnostic Accuracy and Safety of Coaxial System in Oncology Patients Treated in a Specialist Cancer Center With Prospective Validation Within Clinical Trial Data
Khurum Khan, Reyes Gonzalez-Exposito, David Cunningham, et al.
Hemasphere
|
December 13, 2021
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma
Graham P Collins, Toby A Eyre, Debora Schmitz-Rohmer, et al.
Journal of AOAC International
|
August 14, 2017
AOAC SMPR® 2017.004
Brian T Schaneberg, Paula N Brown, Anton Bzhelyansky, et al.
Carcinogenesis
|
July 7, 2016
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients
Francesco Sclafani, Ian Chau, David Cunningham, et al.
Page
of 63